Treatment and outcomes of minor salivary gland cancers of the larynx and trachea: a systematic review
CONCLUSIONS: In case of MiSGC of the larynx and trachea, surgery remains the mainstay of treatment. Adjuvant treatments are frequently delivered. Survival estimates are good overall, but highly heterogeneous.PMID:37814980 | DOI:10.14639/0392-100X-N2635
Source: Acta Otorhinolaryngologica Italica - Category: ENT & OMF Authors: Claudia Montenegro Davide Mattavelli Davide Lancini Alberto Paderno Elisa Marazzi Vittorio Rampinelli Michele Tomasoni Cesare Piazza Source Type: research
More News: Adenoids | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | ENT & OMF | Laryngeal Cancer | Montenegro Health | Salivary Gland Cancer | Tracheal Cancer